Listen to our latest feature in the Molecule to Market podcast!
Qinecsa CEO Adam Sherlock joins host Raman Sehgal to share his insights from nearly four decades in the life sciences industry. From pharma and IVD to medtech and biotech, Adam brings a seasoned, no-nonsense perspective on what drives value in the pharma services space.
In this episode, they explore:
🔹 How timing, gut instinct, and market dynamics shape M&A success
🔹 The moments when it is the right time to go to market or walk away
🔹 Why collaboration beats competition, and how the best deals are often built on trust
🔹 How AI is set to transform R&D services and why we all need to “eat our own lunch”
Packed with industry-specific takeaways, this episode is a must-listen for professionals across drug development and pharmacovigilance.
Listen now:
Spotify: https://lnkd.in/drhbWyVF
Apple: https://lnkd.in/dBM_KG5f
Amazon: https://lnkd.in/dGphig4j
Qinecsa CEO Adam Sherlock joins host Raman Sehgal to share his insights from nearly four decades in the life sciences industry. From pharma and IVD to medtech and biotech, Adam brings a seasoned, no-nonsense perspective on what drives value in the pharma services space.
In this episode, they explore:
🔹 How timing, gut instinct, and market dynamics shape M&A success
🔹 The moments when it is the right time to go to market or walk away
🔹 Why collaboration beats competition, and how the best deals are often built on trust
🔹 How AI is set to transform R&D services and why we all need to “eat our own lunch”
Packed with industry-specific takeaways, this episode is a must-listen for professionals across drug development and pharmacovigilance.
Listen now:
Spotify: https://lnkd.in/drhbWyVF
Apple: https://lnkd.in/dBM_KG5f
Amazon: https://lnkd.in/dGphig4j
